Head, Clinical Operations, Beat AML, a division of The Leukemia & Lymphoma Society
Len Rosenberg, PhD, RPh
Dr. Rosenberg is a 40-year executive with proven experience in driving operational excellence at all levels within the pharmaceutical, biotechnology, eclinical and contract research organization sectors. With his diverse background which includes executive management, clinical and regulatory operations, business development, eclinical technology solutions and new product/licensing evaluations, he brings tremendous hands on insights to optimizing the drug development cycle, from the early start-up stage to global product registration.
Dr. Rosenberg is Head, Clinical Operations at Beat AML, LLC, a division of The Leukemia & Lymphoma Society (since 2016) and Managing Partner of eP2Consulting, Inc (since 2001). He is the co-founder of several companies in the biotech & clinical services sector and a board member at multiple companies including non-profits. Dr. Rosenberg received his Ph.D., from the Kellogg Pharmaceutical Clinical Scientist Program, University of Minnesota, College of Pharmacy and his Bachelor of Science, Pharmacy, from the Philadelphia College of Pharmacy and Science.
Contact Information:
4 Quail Court, Mount Laurel, NJ 08054 (c: 609-923-9443)